LGND
Ligand Pharmaceuticals, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$202.91
-8.57 ▼ -4.05%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$200.00
-2.91 ▼ -1.43%
| Index | RUT | P/E | 34.78 | EPS (ttm) | 5.83 | Insider Own | 2.61% | Shs Outstand | 0.02B | Perf Week | 0.5% |
| Market Cap | 4.05B | Forward P/E | 20.5 | EPS next Y | 14.73% | Insider Trans | -8.58% | Shs Float | 0.02B | Perf Month | 9.11% |
| Enterprise Value | 3.76B | PEG | 2.49 | EPS next Q | 1.84 | Inst Own | 104.08% | Short Float | 7.1% | Perf Quarter | 10.26% |
| Income | 0.12B | P/S | 15.09 | EPS this Y | 6.1% | Inst Trans | -0.41% | Short Ratio | 6.4 | Perf Half Y | 21.46% |
| Sales | 0.27B | P/B | 3.94 | EPS next 5Y | 8.22% | ROA | 9.95% | Short Interest | 1.38M | Perf YTD | 7.32% |
| Book/sh | 51.44 | P/C | 5.52 | EPS past 3/5Y | - | ROE | 13.47% | 52W High | -10.97% ($227.92) | Perf Year | 92.11% |
| Cash/sh | 36.78 | P/FCF | 82.73 | Sales past 3/5Y | 10.96% 7.54% | ROIC | 8.48% | 52W Low | 116.83% ($93.58) | Perf 3Y | 201.32% |
| Dividend Est. | - | EV/EBITDA | 45.7 | EPS Y/Y TTM | 12825.45% | Gross Margin | 82.37% | Volatility(W/M) | 7.58% 5.07% | Perf 5Y | 90.83% |
| Dividend TTM | - | EV/Sales | 14.04 | Sales Y/Y TTM | 60.4% | Oper. Margin | 17.61% | ATR (14) | 10.78 | Perf 10Y | 208.8% |
| Dividend Ex-Date | 2010/7/2 | Quick Ratio | 21.98 | EPS Q/Q | 229.31% | Profit Margin | 46.42% | RSI (14) | 52.18 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 22.23 | Sales Q/Q | 39.37% | SMA20 | 2.22% ($198.5) | Beta | 1.18 | Target Price | $244.5 |
| Payout | - | Debt/Eq | 0.44 | Earnings | 2000000 | SMA50 | 3.35% ($196.33) | Rel Volume | 1.27 | Prev Close | $211.48 |
| Employees | 47 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | 34.93% 7.33% | SMA200 | 19.45% ($169.87) | Avg Volume(3M) | 0.22M | Price | $202.91 |
| IPO | 1992/11/18 | Option/Short | Yes/Yes | Trades | 5284 | Volume | 273,480 | Change | -4.05% |
뉴스 로딩 중...